Search Results - "Cooper, Stacy L"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Treatment of Pediatric Acute Lymphoblastic Leukemia by Cooper, Stacy L., MD, Brown, Patrick A., MD

    Published in The Pediatric clinics of North America (01-02-2015)
    “…Acute lymphoblastic leukemia (ALL) is the most common pediatric oncologic diagnosis, and advances in its treatment have led to progressive improvements in…”
    Get full text
    Journal Article
  2. 2

    Universal premedication and therapeutic drug monitoring for asparaginase‐based therapy prevents infusion‐associated acute adverse events and drug substitutions by Cooper, Stacy L., Young, David J., Bowen, Caitlin J., Arwood, Nicole M., Poggi, Sarah G., Brown, Patrick A.

    Published in Pediatric blood & cancer (01-08-2019)
    “…Background Asparaginase is a critical component of lymphoblastic leukemia therapy, with intravenous pegaspargase (PEG) as the current standard product. Acute…”
    Get full text
    Journal Article
  3. 3

    Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia by Conneely, Shannon E., Cooper, Stacy L., Rau, Rachel E.

    Published in Frontiers in oncology (16-07-2020)
    “…An essential component of acute lymphoblastic leukemia (ALL) therapy is the prolonged maintenance phase with daily 6-mercaptopurine (6-MP) as the cornerstone…”
    Get full text
    Journal Article
  4. 4

    Design and initial user experience of a computer-based decision-support tool to improve safety of chemotherapy delivery by Hanlon, Caitlin, Goldberg, Harry, Liang, Angela, Spjut, Aaron, Cooper, Stacy L.

    Published in Health and technology (01-07-2023)
    “…Purpose Treatments for pediatric cancer require complex management schemes. Providers must ensure that dosages integrate on-going patient parameters into a…”
    Get full text
    Journal Article
  5. 5

    SOHO State of the Art Updates and Next Questions | Optimal Timing of Blinatumomab for the Treatment of B-Acute Lymphoblastic Leukemia by Pinchinat, Ashley, Gupta, Sumit, Cooper, Stacy L., Rau, Rachel E.

    Published in Clinical lymphoma, myeloma and leukemia (01-03-2023)
    “…Blinatumomab is a CD19 targeting bi-specific T-cell engager antibody construct developed for the treatment of CD19 expressing B-cell malignancies. Numerous…”
    Get full text
    Journal Article
  6. 6

    Post-Chemotherapy Titer Status and Need for Revaccination After Treatment for Childhood Cancer by Zhang, Lindy, Thornton, Clifton P., Ruble, Kathy, Cooper, Stacy L.

    Published in Clinical pediatrics (01-06-2020)
    “…Objectives. To evaluate the strategy of checking vaccine titers after completion of chemotherapy. Study Design. Retrospective review of pediatric oncology…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Improving Detection of Cancer Predisposition Syndromes in Pediatric Oncology by Knoll, Jasmine, Li, Ashley, Smith, Christy H., Schratz, Kristen, Cooper, Stacy L., Meah, Tarek, Helmke, Elizabeth, Pratilas, Christine A., Bodurtha, Joann

    Published in Journal of pediatric hematology/oncology (01-08-2021)
    “…Implementation and adherence to consensus statement criteria for referral of pediatric cancer patients for genetic evaluation are critical to identify the 5%…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus by Cooper, Stacy L., Arceci, Robert J., Gamper, Christopher J., Teachey, David T., Schafer, Eric S.

    Published in Pediatric blood & cancer (01-02-2016)
    “…Sinus histiocytosis with massive lymphadenopathy (SHML), or Rosai–Dorfman disease (RDD), is a non‐neoplastic, lymphoproliferative disorder that usually…”
    Get full text
    Journal Article
  11. 11

    Addressing Schooling in Children With Cancer—It's Everybody's Job, So It's Nobody's Job: An Explanatory Mixed-Methods Evaluation by Thornton, Clifton P., Henegan, Sydney, Carey, Lisa B., Milla, Kim, Cork, Katrina, Cooper, Stacy L., Jacobson, Lisa A., Ruble, Kathy, Paré-Blagoev, E. Juliana

    “…Background: Neurocognitive deficits from childhood cancer treatment are common, long-standing, and negatively impact multiple domains of life leading to…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Optimal Timing of Blinatumomab for the Treatment of B-Lymphoblastic Leukemia by Gupta, Sumit, Cooper, Stacy L., Rau, Rachel E.

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)
    “…Blinatumomab is a CD19-targeting bi-specific T-cell engager antibody construct developed for the treatment of CD19-expressing B-cell malignancies. After early…”
    Get full text
    Journal Article
  14. 14

    Research and Care Networks in Acute Leukemia As a Model for Global Healthcare Collaboration by Guscott, Martin R, Cooper, Stacy L, Bagai, Poonam, Bleyer, Archie, Buddington, Randal K, Douer, Dan, Chong, Tina B, Combs, Ryan R, Hylton, Jennifer L, Ines-Villanueva, Gabriela, Lowe, Jennifer A, Pandey, Rishabh, Patel, Aman N, Howard, Scott C

    Published in Blood (23-11-2021)
    “…Introduction: Clinicians in academia face four major career challenges: 1.Gaining clinical advice from colleagues experienced in a particular disease or…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Improving Detection of Cancer Predisposition Syndromes in Pediatric Oncology by Knoll, Jasmine, Li, Ashley, Smith, Christy H., Schratz, Kristin E., Cooper, Stacy L., Meah, Tarek, Helmke, Elizabeth, Pratilas, Christine A., Bodurtha, Joann

    Published in Journal of pediatric hematology/oncology (23-12-2020)
    “…Implementation and adherence to consensus statement criteria for referral of pediatric cancer patients for genetic evaluation are critical to identify the 5%…”
    Get full text
    Journal Article